EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer

Cinzia Garofalo, Stefania Scicchitano, Eleonora Vecchio, Antonia Nisticò, Barbara Quaresima, Beatrice Stella, Carmela De Marco, Flavia Biamonte, Maria Concetta Faniello

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl46641 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, 2026. Written by Cinzia Garofalo and 8 co-authors. Institution: Research Center of Biochemistry and Advanced Molecular Biology, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catan…. Major MEDLINE topics: Killer Cells, Natural, Ovarian Neoplasms, Ferroptosis, Carbolines. 71 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

High-grade ovarian cancer (HGOC) is a heterogeneous and aggressive malignancy with a tumor microenvironment (TME) that suppresses immune responses, limiting immunotherapy efficacy. Ferroptosis, an iron-dependent form of regulated cell death, has emerged as a potential therapeutic target.

Methods

We investigated the immunomodulatory effects of the ferroptosis inducer RAS-Selective Lethal 3 (RSL3) in four HGOC cell lines (ES-2, OVCAR-5, HEY, PEO-1) using flow cytometry and lactate dehydrogenase (LDH) release assays.

Results

RSL3 modulated Natural Killer (NK) ligand expression in a cell line-dependent manner, resulting in differential susceptibility to NK cell-mediated cytotoxicity. OVCAR-5 cells became more susceptible to NK cell killing after treatment, whereas HEY cells showed reduced susceptibility, and ES-2 and PEO-1 cells exhibited minimal changes.

Conclusions

Ferroptosis induction alone does not consistently enhance NK cell-mediated cytotoxicity in HGOC cells. These findings underscore the heterogeneity of tumor responses and highlight the need for further studies, particularly in in vivo models, to elucidate mechanisms linking ferroptosis to immune recognition and thereby inform therapeutic development.

Subjects

MeSH terms (MEDLINE)

Killer Cells, NaturalOvarian NeoplasmsFerroptosisCarbolinesLymphocyte ActivationHumansFemaleCell Line, TumorTumor MicroenvironmentCytotoxicity, Immunologic

Author keywords

NK cellsRSL3ferroptosishigh-grade ovarian cancertumor microenvironment

Substances

CarbolinesRSL3 compound

Authors and institutions

  • Research Center of Biochemistry and Advanced Molecular Biology, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.
  • SOC di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliero Universitaria "Renato Dulbecco", 88100 Catanzaro, Italy.
  • Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Campus "S. Venuta", 88100 Catanzaro, Italy.

Cite

APA

Garofalo, C., Scicchitano, S., Vecchio, E., Nisticò, A., Quaresima, B., Stella, B., De Marco, C., Biamonte, F., & Faniello, M. C. (2026). Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46641

Vancouver

Garofalo C, Scicchitano S, Vecchio E, Nisticò A, Quaresima B, Stella B, et al. Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl46641

BibTeX
@article{Garofalo2026,
  author = {Garofalo, Cinzia and Scicchitano, Stefania and Vecchio, Eleonora and Nisticò, Antonia and Quaresima, Barbara and Stella, Beatrice and De Marco, Carmela and Biamonte, Flavia and Faniello, Maria Concetta},
  title = {Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl46641}
}
Start for free →